Skip to main content

Table 1 Laboratory data of the patient upon admission to our hospital

From: Multiple thrombosis associated with Cytomegalovirus enterocolitis in an immunocompetent patient: a case report

Parameter

Recorded value

Standard value

White blood cell count, cells/L

14.54 × 109

4.5–7.5 × 109

 Neutrophils, %

34.0

42–74

 Eosinophil, %

50.5

0–7.0

Hemoglobin, g/L

102

113–152

Platelet count, cells/L

6 × 109

130–350 × 109

Prothrombin time/International normalized ratio

4.37

0.80–1.20

Activated partial thromboplastin time, s

154.1

26.9–38.1

D-dimer, mg/L

2.1

< 1.0

Fibrin degradation product, mg/L

3.6

0–5.0

Fibrinogen, g/L

2.97

2.00–4.00

Antithrombin III, %

37.2

70–120

C-reactive protein, nmol/L

184.77

≤5.71

Total protein, g/L

71

69–84

Albumin, g/L

18

39–51

Total bilirubin, mmol/L

0.0308

0.0034–0.0205

Aspartate aminotransferase, μkat/L

0.32

0.18–0.5

Alanine aminotransferase, μkat/L

0.47

0.07–0.5

Lactase dehydrogenase, μkat/L

4.55

1.8–3.6

alkaline phosphatase, μkat/L

25.02

1.67–5.83

γ- glutamyltransferase, μkat/L

1.62

0.17–0.83

Creatine kinase, μkat/L

0.93

0.67–2.5

Blood urea nitrogen, mmol/L

9.43

2.86–7.14

Creatinine, mmol/L

0.06

0.05–0.09

Sodium, mmol/L

136

136–148

Potassium, mmol/L

4.5

3.6–5.0

Chloride, mmol/L

107

98–108

soluble interleukin-2 receptor, U/mL

8540

140–520

IgG4, μmol/L

28.62

0.33–7.80

IgE, U/mL

20,367

≤173

P-ANCA

–

 

C-ANCA

–

 

Antinuclear antibody

40 times

<  80 times

C7-HRP

0

 

TAT, ng/mL

2.6

0.0–3.9

PIC, μg/mL

< 0.2

0.0–0.8

Haptoglobin, mg/dL

126

71–160

Activation of factor II, %

49.1

66–118

Activation of factor V, %

< 1.0

73–122

Activation of factor X, %

59.7

58–200

Protein C, %

37%

70–140%

Protein S, %

64.1%

63–149%

Cardiolipin antibody IgG, U/mL

25

0–9

Cardiolipin antibody IgM, U/mL

3

0–7

Anti-human beta-2 glycoprotein 1 Antibody, U/mL

< 1.3

0.0–3.4

lupus anticoagulant

Unknown

0.0–1.2

Activation of ADAMTS13, %

18

≥78

  1. C-ANCA cytoplasmic anti-neutorophil antibody, C7-HRP cytomegalovirus pp65 antigen, P-ANCA perinuclear anti-neutorophil antibody, PIC plasmin-α2 plasmin inhibitor complex, TAT thrombin anti-thrombin complex